Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Market Cap	2.70B +46.3%
Revenue (ttm)	1.47B -0.5%
Net Income	96.61M +124.8%
EPS	4.09 +125.1%
Shares Out	23.66M
PE Ratio	27.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,992
Average Volume	6,242
Open	120.07
Previous Close	117.72
Day's Range	111.84 - 123.60
52-Week Range	70.61 - 202.06
Beta	0.00
RSI	49.99
Earnings Date	May 26, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 406
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BAFNAPH

Financial Performance

In fiscal year 2025, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.53 million, a decrease of -43.49%.